| A study by the
University of Oxford’s Regulatory Policy Institute has found that
Department of Health claims about the savings that can be delivered
through the use of reverse auctions are exaggerated. They also point out
that the approach can, in fact, lead to higher prices or lower-quality
products being supplied that cost more in the long run. Tim Keyworth
and George Yarrow, the report’s authors, said: “We do not think the
claims made for eAuctions would long survive the rigorous scrutiny of an
external audit by a body like the NAO.”
Access the full report:
Reverse eAuctions and NHS procurement on the website of the
Association for British Healthcare Industries.
Full story in bjhc&im June 2006 (487 words)
|